1Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892.
Clinical trials for Alzheimer's disease (AD) patients are generally not confounded by learning effects. However, cognitive impairment severity may influence learning capacity, necessitating caution, especially in controls and mild AD cases.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: